Početna › Neuroblastom › Pennsylvania
Kliničke studije za Neuroblastom u državi Pennsylvania
14 studija za Neuroblastom traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Children's Hospital of Philadelphia, Philadelphia
- i još 2
U tijeku regrutacijaFaza 3
Do 30 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 2
Do 22 godina · Oba spola · Ažurirano 4. ruj 2026. · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 2
Od 1 do 21 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- i još 2
U tijeku regrutacijaFaza 3
365 Days – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 2
12 Months – 21 Years · Oba spola · Ažurirano 12. kol 2026. · NCT05489887SPEARHEAD-3 Pediatric Study
- Children's Hospital of Philedephia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 2 do 21 godina · Oba spola · Ažurirano 11. kol 2026. · NCT05642455PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 1 do 30 godina · Oba spola · Ažurirano 22. srp 2026. · NCT06721689NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 2
Od 1 do 31 godina · Oba spola · Ažurirano 20. srp 2026. · NCT06450041Neuroblastoma Biology Study
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaOpažajna studija
31 Days – 99 Years · Oba spola · Ažurirano 23. ožu 2026. · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacija
Do 17 godina · Oba spola · Ažurirano 10. velj 2026. · NCT06831552Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.